Altamont Pharmaceutical Holdings logo

Altamont Pharmaceutical Holdings

North America, California, United States, San Jose

Description

Altamont Pharmaceutical Holdings is an investment management firm seeking to invest in small cap and publicly traded biotech companies.

Investor Profile

Altamont Pharmaceutical Holdings has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Altamont Pharmaceutical Holdings frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
PC
North America, New York, United States, New York
Co-Investments: 1
Point72
North America, Connecticut, United States, Stamford
Co-Investments: 1
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1
Samlyn Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Altamont Pharmaceutical Holdings often collaborate with?

RA
North America, United States
Shared Deals: 1

What are some of recent deals done by Altamont Pharmaceutical Holdings?

Corvus Pharmaceuticals

Burlingame, California, United States

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityMay 2, 2024
Amount Raised: $30,600,000